Persei vivarium advances an integrated solution for the continuous follow-up of oncology patients

by Persei vivarium, June 10, 2026

The rising incidence of cancer, increasing healthcare system pressure, and the growing complexity of treatments are transforming cancer care delivery and creating new challenges for healthcare professionals and health systems.

According to REDECAN estimates, 301,884 new cancer cases are expected to be diagnosed in Spain in 2026. This is compounded by increasing survival rates and population ageing, both of which are driving growth in the number of patients requiring continuous and personalized follow-up beyond the hospital setting.

At the same time, the administration of oncology treatments presents clinical challenges related to the management of adverse events and, particularly in the case of oral therapies, the maintenance of treatment adherence. These factors can significantly impact both patients’ quality of life and treatment continuity. Studies have shown that approximately 28% of patients experience some degree of non-adherence to oral cancer treatments, a key factor influencing treatment effectiveness and clinical outcomes.

A digital solution designed for oncology patients

In this context, Persei vivarium by Zelenza Group offers an integrated digital solution designed specifically for oncology patients to improve clinical monitoring, support the early detection of treatment-related toxicities, and promote the appropriate administration and adherence to therapy.

The solution combines digital patient follow-up tools, personalized educational programs, and advanced clinical monitoring capabilities to optimize continuity of care and support data-driven decision-making.

The integrated approach of this solution supports the transition towards a more personalized, proactive, and efficient model of care, enhancing clinical follow-up and improving health outcomes for oncology patients. This enables healthcare organizations to address key priorities such as reducing unnecessary visits, optimizing clinical follow-up and the use of high-cost therapies, and improving healthcare efficiency.

Currently implemented in several hospitals, the solution is expected to continue expanding its adoption, helping address healthcare system challenges while ultimately improving outcomes and quality of life for oncology patients.